| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12077-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2730-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75193-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61126-0.025mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP3-18522-100ug | |||
| Biotin | NBP3-18522-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34897-10ug | |||
| Carrier-Free | NBP2-34897-1mg | |||
| Carrier-Free | NBP2-34897-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75906SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81098-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75198-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12004-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81081-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50475-0.025ml | |||
![Immunocytochemistry/Immunofluorescence: CD53 Antibody (161-2 (53/2)) - Chimeric [NBP3-12077] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 161-2 (53/2) (NBP3-12077) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12077, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD53-Antibody-161-2-53-2-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12077-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD53 Antibody (161-2 (53/2)) - Chimeric [NBP3-12077] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 161-2 (53/2) (NBP3-12077) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12077, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Immunofluorescence: IL6R Antibody (rhPM-1 (Tocilizumab)) - Chimeric [NBP2-75193] - Immunofluorescence staining of fixed U937 cells with anti-IL-6 receptorantibody rhPM-1 (Tocilizumab). Immunofluorescence analysis of paraformaldehyde fixed U937 cells on coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of rhPM-1 (Tocilizumab) (NBP2-75193) at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-75193, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/IL6R-Antibody-rhPM-1-Tocilizumab-Chimeric-Immunofluorescence-NBP2-75193-img0001.jpg "Immunofluorescence: IL6R Antibody (rhPM-1 (Tocilizumab)) - Chimeric [NBP2-75193] - Immunofluorescence staining of fixed U937 cells with anti-IL-6 receptorantibody rhPM-1 (Tocilizumab). Immunofluorescence analysis of paraformaldehyde fixed U937 cells on coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of rhPM-1 (Tocilizumab) (NBP2-75193) at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-75193, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![Western Blot: IL-4 Antibody (V17P1B4*B12) [Ovalbumine] - Azide and BSA Free [NBP2-61126] - Western blot image showing detection of recombinant IL4-4B1 (200 ng) using Anti-IL4-4B1 [V17P1B4*B12] at 1/2 dilution. Arrow indicates a correct band of 18 KDa.](http://images.novusbio.com/fullsize/IL-4-Antibody-V17P1B4-B12-Ovalbumine-Azide-and-BSA-Free-Western-Blot-NBP2-61126-img0001.jpg "Western Blot: IL-4 Antibody (V17P1B4*B12) [Ovalbumine] - Azide and BSA Free [NBP2-61126] - Western blot image showing detection of recombinant IL4-4B1 (200 ng) using Anti-IL4-4B1 [V17P1B4*B12] at 1/2 dilution. Arrow indicates a correct band of 18 KDa.")
![SDS-Page: Recombinant Human MIF His Avi-tag Protein [Biotin] [NBP3-18522] - Western blot under reducing and non-reducing conditions](http://images.novusbio.com/fullsize/Recombinant Human MIF His Avi-tag Protein [Biotin]-SDS-Page-NBP3-18522-img0001.jpg "SDS-Page: Recombinant Human MIF His Avi-tag Protein [Biotin] [NBP3-18522] - Western blot under reducing and non-reducing conditions")
![SDS-Page: Human IL-5 Protein [NBP2-34897]](http://images.novusbio.com/fullsize/Human-IL-5-Protein-SDS-Page-NBP2-34897-img0002.jpg "SDS-Page: Human IL-5 Protein [NBP2-34897]")
![Flow Cytometry: Siglec-3/CD33 Antibody (hP67.6 (Gemtuzumab)) - Chimeric [NBP2-75906] - Human leukocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of hP67.6 (Gemtuzumab) (NBP2-75906, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-3-CD33-Antibody-hP67-6-Gemtuzumab-Chimeric-Flow-Cytometry-NBP2-75906-img0001.jpg "Flow Cytometry: Siglec-3/CD33 Antibody (hP67.6 (Gemtuzumab)) - Chimeric [NBP2-75906] - Human leukocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of hP67.6 (Gemtuzumab) (NBP2-75906, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FACSCanto flow-cytometer.")
![Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (H22) - Chimeric [NBP2-81098] - Immunofluorescence staining of fixed U937 cells with Fc gamma RI/CD64 Antibody (H22) [NBP2-81098]. Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of H22 [NBP2-81098] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81098, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-H22-Chimeric-Immunocytochemistry-Immunofluorescence-NBP2-81098-img0001.jpg "Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (H22) - Chimeric [NBP2-81098] - Immunofluorescence staining of fixed U937 cells with Fc gamma RI/CD64 Antibody (H22) [NBP2-81098]. Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of H22 [NBP2-81098] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81098, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.](http://images.novusbio.com/fullsize/nbp2-75198_rabbit-monoclonal-cd27-tnfrsf7-antibody-rm27-3e5-chimeric-7420252228563.png "ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.")
![Immunocytochemistry/Immunofluorescence: IL-7R alpha/CD127 Antibody (YIL7R323) [NBP2-81081] - Immunofluorescence staining of fixed human peripheral blood monocytes (PBMs) with IL-7R alpha/CD127 Antibody (YIL7R323) [NBP2-81081]. Immunofluorescence analysis of paraformaldehyde fixed human PBMs on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of YIL7R323 [NBP2-81081] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81081, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/IL-7R-alpha-CD127-Antibody-YIL7R323-Immunocytochemistry-Immunofluorescence-NBP2-81081-img0001.jpg "Immunocytochemistry/Immunofluorescence: IL-7R alpha/CD127 Antibody (YIL7R323) [NBP2-81081] - Immunofluorescence staining of fixed human peripheral blood monocytes (PBMs) with IL-7R alpha/CD127 Antibody (YIL7R323) [NBP2-81081]. Immunofluorescence analysis of paraformaldehyde fixed human PBMs on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of YIL7R323 [NBP2-81081] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81081, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")